A study on hematological and immunological profile of patients with systemic Lupus Erythematosus

  • Dr. Akshatha. N Department of Pathology, Gadag Institute of Medical Sciences, Mallasamudra, Gadag, Karnataka, India.
  • Dr. Shwetha Patil Department of Pathology, Gadag Institute of Medical Sciences, Mallasamudra, Gadag, Karnataka, India.
Keywords: SLE, Haematological, Serological, Anca, Esr

Abstract

Background: Systemic lupus erythematosus (SLE) is a chronic, relapsing, inflammatory and often febrile multisystem disorder of the connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. Hematological findings may be present at the onset of the disease or can develop during the course of the disease. Since blood and blood vessels together contain more diverse number of antigens than any other organ in the body, it is only natural to expect hematological manifestations more often than the other systems.

Objectives: To study the haematological and immunological Profile of Patients with Systemic Lupus Erythematosis.

Methodology: An Ambispective study was conducted at Kasturba Medical College and hospital, Manipal from January 2011 to December 2013. A total of One hundred twenty seven cases of SLE were classified as having SLE according to the revised American College of Rheumatology (ACR) classification criteria (1997).

Results: Hematological manifestations were frequently seen in the cases studied, which included anemia, neutropenia, lymphopenia, thrombocytopenia, pancytopenia, increased Erythrocyte sedimentation rate (ESR), presence of spherocytes, DCT positivity etc.Anemia was the most common hematological abnormality observed in the patients accounting to 87.4% (111/127) of cases. Hemoglobin of patients varied from a minimum of 3.8g/dl up to 13.5g/dl (Median = 9.6±2.2). The erythrocyte sedimentation rate (ESR) was assessed in all except one.The PCNA (Anti proliferating cell nuclear antigen) antibodies were positive in 44% of the cases.

Conclusion: Hematological abnormalities are the commonest among all other anifestations in SLE, and their treatment is challenging. Bone marrow examination should be considered in all cases of severe or persistent leukopenia or thrombocytopenia in SLE, to exclude dug-induced myelotoxicity in susceptible patients.

Downloads

Download data is not yet available.

References

1. Rus V, Maury EE, Hochberg MC. The epidemiology of systemic lupus erythematosus. In: Dubois' Lupus Erythematosus, Wallace DJ, Hahn BH (Eds), Lippincott Williams and Wilkins, Philadelphia 2002.

2. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40 (9):1725. doi:10.1002/art.1780400928

3.Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum.1982;25(11):1271-7.doi:10.1002/art.1780251101

4. Sasidharan PK. SLE as a hematological disease. In: Agarwal MB, editor. Hematolgy Today. Mumbai, India: Vikas Publications; 2010. pp. 953–966.

5. Aleem A, Al Arfaj AS, khalil N, Alarfaj H. Haematological abnormalities in systemic lupus erythematosus. Acta Reumatol Port. 2014;39(3):236-41.

6. Hu XM, Fan ZR, Zhou SY, Wei W, Zhu BH, Cao YF. [Hematological abnormality and clinical characteristics in systemic lupus erythematosus]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004;12(2): 170-3.

7. Sasidharan PK, Bindya M, Sajeeth Kumar KG. Hematological Manifestations of SLE at Initial Presentation: Is It Underestimated?ISRNHematol. 2012; 2012: 961872. doi: 10.5402/2012/961872.

8. Fathi H, Ahmed EF, Abdelgawad MM, Elbayoumi Y. Cutaneous manifestations of systemic lupus erythematosus : a retrospective study from Egypt. Gulf J dermatology Venerol. 2010;17(1):36–42.

9. Paudyal BP, Gyawalee M. Clinical profile of patients with systemic lupus erythematosus. JNMA J Nepal Med Assoc. 2012;52(187):111-7.

10. Agrawal S, Jain A, Rajput A, Tiewsoh I. A crosssectional hospital based study of clinical and immunological profile of systemic lupus erythematosus patients from central rural India. Indian J Allergy, Asthma Immunol. 2013;27(1):33.doi: 10.4103/0972-
6691. 116614

11. Chen JL, Huang XM, Zeng XJ, Wang Y, Zhou MX, Ma YH, et al. Hematological abnormalities in systemic lupus erythematosus and clinical significance thereof: comparative analysis of 236 cases. Zhonghua Yi Xue Za Zhi. 2007;87(19):1330-1333. doi: 10.3760/j: Issn:0376-2491.2007.19.010

12. Beyan E, Beyan C, Turan M. Hematological presentation in systemic lupus erythematosus and its relationship with disease activity. Hematol. 2007; 12(3): 257-61. doi:10.1080/10245330701214145

13.Voulgarelis M, Giannouli S, Tasidou A, Anagnostou D, Ziakas PD, Tzioufas AG. Bone marrow histological findings in systemic lupus erythematosus with hematologic abnormalities: a clinicopathological study. Am J Hematol. 2006; 81(8):590-7. doi:10.1002/ajh. 20593

14. Saigal R, Kansal A, Mittal M, Singh Y, Maharia HR, Juneja M. Clinical profile of systemic lupus erythematosus patients at a tertiary care centre in Western India. J Indian AcadClin Med .2011;13:27-32.

15. Binoy JP, Muhammed F, Kumar N, Razia MV. Clinical profile of systemic lupus erythematosus in North Kerala. J Indian RheumatolAssoc.2003;11:94-7.
CITATION
DOI: 10.17511/jopm.2019.i07.15
Published: 2019-07-31
How to Cite
Dr. Akshatha. N, & Dr. Shwetha Patil. (2019). A study on hematological and immunological profile of patients with systemic Lupus Erythematosus. Tropical Journal of Pathology and Microbiology, 5(7), 505-511. https://doi.org/10.17511/jopm.2019.i07.15
Section
Original Article